| 1 |
Vandorpe DH, Heneghan JF, Waitzman JS, McCarthy GM, Blasio A, Magraner JM, Donovan OG, Schaller LB, Shah SS, Subramanian B, Riella CV, Friedman DJ, Pollak MR, Alper SL. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes. Pflugers Arch 2023;475:323-41. [PMID: 36449077 DOI: 10.1007/s00424-022-02767-8] [Reference Citation Analysis]
|
| 2 |
Pays E, Radwanska M, Magez S. The Pathogenesis of African Trypanosomiasis. Annu Rev Pathol 2023;18:19-45. [PMID: 36055769 DOI: 10.1146/annurev-pathmechdis-031621-025153] [Reference Citation Analysis]
|
| 3 |
Pollak MR, Friedman DJ. APOL1-Associated Kidney Disease. Emery and Rimoin' s Principles and Practice of Medical Genetics and Genomics 2023. [DOI: 10.1016/b978-0-12-812534-2.00007-2] [Reference Citation Analysis]
|
| 4 |
Lv Y, Tang W, Xu Y, Chang W, Zhang Z, Lin Q, Ji M, Feng Q, He G, Xu J. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. Int J Biol Sci 2023;19:1284-98. [PMID: 36923931 DOI: 10.7150/ijbs.74985] [Reference Citation Analysis]
|
| 5 |
Yoshida T, Latt KZ, Rosenberg AZ, Shrivastav S, Heymann J, Halushka MK, Winkler CA, Kopp JB. Transcriptomic Analysis of Human Podocytes In Vitro: Effects of Differentiation and APOL1 Genotype. Kidney Int Rep 2023;8:164-78. [PMID: 36644347 DOI: 10.1016/j.ekir.2022.10.011] [Reference Citation Analysis]
|
| 6 |
Friedman DJ, Ma L, Freedman BI. Treatment potential in APOL1-associated nephropathy. Curr Opin Nephrol Hypertens 2022;31:442-8. [PMID: 35894278 DOI: 10.1097/MNH.0000000000000816] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Adebayo OC, Van den Heuvel LP, Olowu WA, Levtchenko EN, Labarque V. Sickle cell nephropathy: insights into the pediatric population. Pediatr Nephrol 2022;37:1231-43. [PMID: 34050806 DOI: 10.1007/s00467-021-05126-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Gerstner L, Chen M, Kampf LL, Milosavljevic J, Lang K, Schneider R, Hildebrandt F, Helmstädter M, Walz G, Hermle T. Inhibition of endoplasmic reticulum stress signaling rescues cytotoxicity of human apolipoprotein-L1 risk variants in Drosophila. Kidney Int 2022;101:1216-31. [PMID: 35120995 DOI: 10.1016/j.kint.2021.12.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Daneshpajouhnejad P, Kopp JB, Winkler CA, Rosenberg AZ. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning. Nat Rev Nephrol 2022. [PMID: 35217848 DOI: 10.1038/s41581-022-00538-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Pays E. Distinct APOL1 functions in trypanosomes and kidney podocytes. Trends Parasitol 2021:S1471-4922(21)00285-3. [PMID: 34887168 DOI: 10.1016/j.pt.2021.11.005] [Reference Citation Analysis]
|
| 11 |
Dhande IS, Braun MC, Doris PA. Emerging Insights Into Chronic Renal Disease Pathogenesis in Hypertension From Human and Animal Genomic Studies. Hypertension 2021;78:1689-700. [PMID: 34757770 DOI: 10.1161/HYPERTENSIONAHA.121.18112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Lesage S, Chazal M, Beauclair G, Batalie D, Cerboni S, Couderc E, Lescure A, Del Nery E, Tangy F, Martin A, Manel N, Jouvenet N. Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner. J Mol Biol 2021;:167277. [PMID: 34599939 DOI: 10.1016/j.jmb.2021.167277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Vastrad B, Vastrad C. Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysis.. [DOI: 10.1101/2021.09.24.461631] [Reference Citation Analysis]
|
| 14 |
McCarthy GM, Blasio A, Donovan OG, Schaller LB, Bock-Hughes A, Magraner JM, Suh JH, Tattersfield CF, Stillman IE, Shah SS, Zsengeller ZK, Subramanian B, Friedman DJ, Pollak MR. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease. Dis Model Mech 2021;14:dmm048952. [PMID: 34350953 DOI: 10.1242/dmm.048952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 15 |
Müller D, Schmitz J, Fischer K, Granado D, Groh AC, Krausel V, Lüttgenau SM, Amelung TM, Pavenstädt H, Weide T. Evolution of renal-disease factor APOL1 results in cis and trans orientations at the endoplasmic reticulum that both show cytotoxic effects. Mol Biol Evol 2021:msab220. [PMID: 34323996 DOI: 10.1093/molbev/msab220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Schaub C, Lee P, Racho-Jansen A, Giovinazzo J, Terra N, Raper J, Thomson R. Coiled-coil binding of the leucine zipper domains of APOL1 is necessary for the open cation channel conformation. J Biol Chem 2021;:101009. [PMID: 34331942 DOI: 10.1016/j.jbc.2021.101009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Ekulu PM, Adebayo OC, Decuypere JP, Bellucci L, Elmonem MA, Nkoy AB, Mekahli D, Bussolati B, van den Heuvel LP, Arcolino FO, Levtchenko EN. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype. Cells 2021;10:1914. [PMID: 34440683 DOI: 10.3390/cells10081914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Ultsch M, Holliday MJ, Gerhardy S, Moran P, Scales SJ, Gupta N, Oltrabella F, Chiu C, Fairbrother W, Eigenbrot C, Kirchhofer D. Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif. Commun Biol 2021;4:916. [PMID: 34316015 DOI: 10.1038/s42003-021-02387-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Lesage S, Chazal M, Beauclair G, Batalie D, Couderc E, Lescure A, Del Nery E, Tangy F, Martin A, Manel N, Jouvenet N. Discovery of genes that modulate flavivirus replication in an interferon-dependent manner.. [DOI: 10.1101/2021.07.20.453077] [Reference Citation Analysis]
|
| 20 |
Pant J, Giovinazzo JA, Tuka LS, Peña D, Raper J, Thomson R. Apolipoproteins L1-6 share key cation channel-regulating residues but have different membrane insertion and ion conductance properties. J Biol Chem 2021;297:100951. [PMID: 34252458 DOI: 10.1016/j.jbc.2021.100951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Bondue T, Arcolino FO, Veys KRP, Adebayo OC, Levtchenko E, van den Heuvel LP, Elmonem MA. Urine-Derived Epithelial Cells as Models for Genetic Kidney Diseases. Cells 2021;10:1413. [PMID: 34204173 DOI: 10.3390/cells10061413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Cornelissen A, Fuller DT, Fernandez R, Zhao X, Kutys R, Binns-Roemer E, Delsante M, Sakamoto A, Paek KH, Sato Y, Kawakami R, Mori M, Kawai K, Yoshida T, Latt KZ, Miller CL, de Vries PS, Kolodgie FD, Virmani R, Shin MK, Hoek M, Heymann J, Kopp JB, Rosenberg AZ, Davis HR, Guo L, Finn AV. APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population. Arterioscler Thromb Vasc Biol 2021;41:2201-14. [PMID: 34039022 DOI: 10.1161/ATVBAHA.120.315788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Freedman BI, Kopp JB, Sampson MG, Susztak K. APOL1 at 10 years: progress and next steps. Kidney Int 2021;99:1296-302. [PMID: 33794228 DOI: 10.1016/j.kint.2021.03.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 24 |
Madhavan SM, Hansen AL, Cao S, Sedor JR, Buck M. Towards the NMR solution Structure and the Dynamics of the C-terminal Region of APOL1 and its G1, G2 Variants with a Membrane Mimetic.. [DOI: 10.1101/2021.03.16.435683] [Reference Citation Analysis]
|
| 25 |
Pays E, Nolan DP. Genetic and immunological basis of human African trypanosomiasis. Curr Opin Immunol 2021;72:13-20. [PMID: 33721725 DOI: 10.1016/j.coi.2021.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 26 |
Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Ge M, Molina J, Ducasa GM, Mallela SK, Varona Santos J, Mitrofanova A, Kim JJ, Liu X, Sloan A, Mendez AJ, Banerjee S, Liu S, Szeto HH, Shin MK, Hoek M, Kopp JB, Fontanesi F, Merscher S, Fornoni A. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis. Hum Mol Genet 2021;30:182-97. [PMID: 33517446 DOI: 10.1093/hmg/ddab022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Shetty AA, Tawhari I, Safar-Boueri L, Seif N, Alahmadi A, Gargiulo R, Aggarwal V, Usman I, Kisselev S, Gharavi AG, Kanwar Y, Quaggin SE. COVID-19-Associated Glomerular Disease. J Am Soc Nephrol 2021;32:33-40. [PMID: 33214201 DOI: 10.1681/ASN.2020060804] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 50.0] [Reference Citation Analysis]
|
| 29 |
Ma L, Palmer ND, Choi YA, Murea M, Snipes JA, Parks JS, Langefeld CD, Freedman BI. APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis. Kidney360 2020;1:1353-1362. [DOI: 10.34067/kid.0003592020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 30 |
Goyal R, Singhal PC. APOL1 risk variants and the development of HIV-associated nephropathy. FEBS J 2021;288:5586-97. [PMID: 33340240 DOI: 10.1111/febs.15677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 31 |
Pays E. The Mechanism of Kidney Disease Due to APOL1 Risk Variants. J Am Soc Nephrol 2020;31:2502-5. [PMID: 32943491 DOI: 10.1681/ASN.2020070954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Li D, Snipes JA, Murea M, Molina AJA, Divers J, Freedman BI, Ma L, Petrovic S. An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation. Am J Nephrol 2020;51:695-704. [PMID: 32866949 DOI: 10.1159/000509989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Pays E. APOL1 variant-associated kidney disease: from trypanosomes to podocyte cytoskeleton. Kidney Int 2020;98:1373-7. [PMID: 32835731 DOI: 10.1016/j.kint.2020.07.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 34 |
Pays E. The function of apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infection. FEBS J 2021;288:360-81. [PMID: 32530132 DOI: 10.1111/febs.15444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Mabille D, Caljon G. Inflammation following trypanosome infection and persistence in the skin. Curr Opin Immunol 2020;66:65-73. [PMID: 32446136 DOI: 10.1016/j.coi.2020.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
